Injecting Lidocaine into ETT Cuff to Reduce Coughing
Yes, it is safe to inject alkalinized lidocaine into an endotracheal tube cuff to reduce coughing, and this practice is supported by multiple high-quality studies showing reduced emergence cough, improved hemodynamic stability, and decreased postoperative sore throat without significant adverse events.
Evidence-Based Recommendation
The use of alkalinized lidocaine (2% lidocaine mixed with 8.4% sodium bicarbonate) in ETT cuffs has been extensively studied and demonstrates clear clinical benefits:
Primary Benefits
- Reduced emergence cough: Studies consistently show 40-55% reduction in coughing incidence compared to air-filled cuffs 1, 2
- Improved hemodynamic stability: Lower systolic and mean arterial pressures during extubation 3, 2
- Decreased postoperative complications: Reduced sore throat incidence (35-65% reduction) and improved phonation recovery 4, 5, 3
- Lower sedation requirements: Trend toward reduced propofol needs in cardiac surgery patients 6
Optimal Technique
Preparation and timing matter significantly:
- Mix 2% lidocaine with 8.4% sodium bicarbonate in a 19:1 or similar ratio 5, 2
- Pre-fill the cuff at least 60-90 minutes before intubation to allow lidocaine diffusion across the cuff membrane 1, 2
- For surgeries <2 hours, pre-filling becomes critical since alkalinized lidocaine requires 60-120 minutes to cross the ETT cuff membrane 1
- Empty the pre-filled cuff immediately before intubation, then re-inflate with the alkalinized lidocaine solution 1
Safety Profile
The evidence demonstrates excellent safety:
- No increase in adverse events compared to air-filled cuffs 6, 1
- Prevention of excessive cuff pressures during nitrous oxide anesthesia (cuff pressures remain significantly lower than air-filled cuffs) 4, 5
- Lower incidence of tracheal mucosal injury compared to conventional air-filled cuffs 4
Important Caveats
Dosing Considerations
While the pediatric guideline 7 emphasizes maximum lidocaine doses of 5 mg/kg for airway topicalization in children, the ETT cuff technique uses minimal systemic absorption. The typical 2 mL of 2% lidocaine (40 mg total) used in adult cuffs represents a small fraction of toxic doses, and the cuff acts as a controlled-release reservoir rather than direct mucosal application.
Contraindications from FDA Labeling
The FDA drug label 8 specifies lidocaine topical products should not be used on mucous membranes in certain contexts, but this refers to direct application of concentrated topical preparations. The ETT cuff technique involves trans-membrane diffusion of diluted lidocaine, which is mechanistically different.
When NOT to Use
- Avoid in patients with known lidocaine allergy
- Use caution with pre-existing cardiac conduction abnormalities (though systemic absorption is minimal) 9
- Not recommended for surgeries <60 minutes unless cuff is pre-filled well in advance 1
Clinical Implementation
For maximum efficacy:
- Pre-fill ETT cuffs with alkalinized lidocaine solution >90 minutes before anticipated intubation
- Store pre-filled cuffs at room temperature or warmed to 38°C (warming may enhance diffusion) 2
- Empty and re-inflate with the same solution after intubation
- Maintain cuff pressure at 20 cmH₂O using standard monitoring 4
- Expect lower cuff pressures throughout the case compared to air-filled cuffs 5
Comparative Evidence
One outlier study 10 found increased POST when lidocaine jelly was applied externally to tapered-shaped cuffs, but this represents a different technique (external application vs. internal cuff filling) and should not be extrapolated to the alkalinized lidocaine cuff inflation technique.
The preponderance of evidence from 2018-2024 1, 3, 6 supports this as a safe, effective intervention that improves patient outcomes without increasing complications.